Did you see the CEO of Aegerion on CNBC this morning? They just got their first drug approved for cholesterol for a market of potentially 6000 patients worldwide and expect first year sales of $75 million. They are up 70% in the past few months and trading at $27+.... can you imagine what CTIX will be at with KEVETRIN a success? Your $800+ might be in the ballpark!!!!